Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

The prevalence of hypertension and abnormal kidney function in children with sickle cell disease –a cross sectional review

Authors: Prasad Bodas, Alex Huang, Mary Ann O’Riordan, John R Sedor, Katherine MacRae Dell

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Renal disease is a known contributor to mortality in adults with sickle cell disease (SCD) and renal abnormalities are evident in childhood. Hyperfiltration (evidenced by elevated glomerular filtration rate, GFR) occurs in children with SCD early in disease. However, the incidence of low GFR (<90 ml/min/1.73 m2) suggestive of chronic kidney disease (CKD), is not well established. The prevalence of hypertension is also not well known. The goal of this study was to determine the prevalence of hypertension and CKD in a cohort of children with SCD.

Methods

We performed a retrospective chart review of patients followed at the Rainbow Babies and Children’s Sickle Cell Disease Clinic who were seen during routine follow up visits. Inclusion criteria were all patients ages 3–18. Exclusion criteria included recent (within 2 weeks) hospitalization and/or episode of acute chest, pain crises, febrile illness or red blood cell transfusion. Data collected included serum creatinine, blood pressure and history of sickle cell complications (acute chest syndrome, stroke or stroke risk). Estimated GFR (eGFR) was calculated using the updated Schwartz creatinine-based estimating formula. Analysis examined the associations among eGFR, blood pressure and sickle cell complications. The Institutional Review Board at University Hospitals Case Medical Center approved this study.

Results

A total of 48 children had complete data available. Mean eGFR was 140 mL/min/1.73 m2 +/- 34.9 (range 71.9-404.2 mL/min/1.73 m2). Four patients (8.3%) had eGFRs < 90 mL/min/1.73 m2, 35 patients (72.9%) had eGFRs > 120 mL/min/1.73 m2 and 9 patients (18.8%) had eGFRs in the normal range. Eight patients (16.7%) had evidence of elevated blood pressures (pre-hypertension or hypertension). There was no correlation between eGFR and age, and no association of eGFR with acute chest or stroke risk.

Conclusion

In this SCD cohort, we identified abnormally low eGFR (suggestive of early CKD) in 8.3% of patients and elevated blood pressure in 16.7%. These findings are in contrast to other published studies that show primarily normal or elevated GFR and the absence of or minimal hypertension. These findings indicate that elevated blood pressure and decreased eGFR are not uncommon in children with SCD, and should be more rigorously studied.
Literature
1.
go back to reference Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP: Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994, 330: 1639-1644. 10.1056/NEJM199406093302303.CrossRefPubMed Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP: Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994, 330: 1639-1644. 10.1056/NEJM199406093302303.CrossRefPubMed
2.
go back to reference Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C: Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med. 1991, 115: 614-620. 10.7326/0003-4819-115-8-614.CrossRefPubMed Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C: Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med. 1991, 115: 614-620. 10.7326/0003-4819-115-8-614.CrossRefPubMed
4.
go back to reference Saborio P, Scheinman JI: Sickle cell nephropathy. J Am Soc Nephrol. 1999, 10: 187-192.PubMed Saborio P, Scheinman JI: Sickle cell nephropathy. J Am Soc Nephrol. 1999, 10: 187-192.PubMed
5.
go back to reference Guasch A, Navarrete J, Nass K, Zayas CF: Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol. 2006, 17: 2228-2235. 10.1681/ASN.2002010084.CrossRefPubMed Guasch A, Navarrete J, Nass K, Zayas CF: Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol. 2006, 17: 2228-2235. 10.1681/ASN.2002010084.CrossRefPubMed
6.
go back to reference Etteldorf JN, Smith JD, Tuttle AH, Diggs LW: Renal hemodynamic studies in adults with sickle cell anemia. Am J Med. 1955, 18: 243-248. 10.1016/0002-9343(55)90239-4.CrossRefPubMed Etteldorf JN, Smith JD, Tuttle AH, Diggs LW: Renal hemodynamic studies in adults with sickle cell anemia. Am J Med. 1955, 18: 243-248. 10.1016/0002-9343(55)90239-4.CrossRefPubMed
7.
go back to reference Whitten CF, Younes AA: A comparative study of renal concentrating ability in children with sickle cell anemia and in normal children. J Lab Clin Med. 1960, 55: 400-415.PubMed Whitten CF, Younes AA: A comparative study of renal concentrating ability in children with sickle cell anemia and in normal children. J Lab Clin Med. 1960, 55: 400-415.PubMed
8.
go back to reference Oster JR, Lespier LE, Lee SM, Pellogrini EL, Vaamonde CA: Renal acidification in sickle-cell disease. J Lab Clin Med. 1976, 88: 389-401.PubMed Oster JR, Lespier LE, Lee SM, Pellogrini EL, Vaamonde CA: Renal acidification in sickle-cell disease. J Lab Clin Med. 1976, 88: 389-401.PubMed
9.
go back to reference Allon M: Renal abnormalities in sickle cell disease. Arch Intern Med. 1990, 150: 501-504. 10.1001/archinte.1990.00390150015003.CrossRefPubMed Allon M: Renal abnormalities in sickle cell disease. Arch Intern Med. 1990, 150: 501-504. 10.1001/archinte.1990.00390150015003.CrossRefPubMed
10.
go back to reference Osegbe DN: Haematuria and sickle cell disease: a report of 12 cases and review of the literature. Trop Geogr Med. 1990, 42: 22-27.PubMed Osegbe DN: Haematuria and sickle cell disease: a report of 12 cases and review of the literature. Trop Geogr Med. 1990, 42: 22-27.PubMed
11.
go back to reference Wigfall DR, Ware RE, Burchinal MR, Kinney TR, Foreman JW: Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr. 2000, 136: 749-753.PubMed Wigfall DR, Ware RE, Burchinal MR, Kinney TR, Foreman JW: Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr. 2000, 136: 749-753.PubMed
12.
go back to reference Ataga K, Orringer E: Renal abnormalities in sickle cell disease. Am J Hematol. 2000, 63: 205-211. 10.1002/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.0.CO;2-8.CrossRefPubMed Ataga K, Orringer E: Renal abnormalities in sickle cell disease. Am J Hematol. 2000, 63: 205-211. 10.1002/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.0.CO;2-8.CrossRefPubMed
13.
go back to reference Tejani A, Phadke K, Adamson O, Nicastri A, Chen CK, Sen D: Renal lesions in sickle cell nephropathy in children. Nephron. 1985, 39: 352-355. 10.1159/000183404.CrossRefPubMed Tejani A, Phadke K, Adamson O, Nicastri A, Chen CK, Sen D: Renal lesions in sickle cell nephropathy in children. Nephron. 1985, 39: 352-355. 10.1159/000183404.CrossRefPubMed
14.
go back to reference Adams R, McKie V, Nichols F, Carl E, Zhang D, McKie K, Figueroa R, Litaker M, Thompson W, Hess D: The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992, 326: 605-610. 10.1056/NEJM199202273260905.CrossRefPubMed Adams R, McKie V, Nichols F, Carl E, Zhang D, McKie K, Figueroa R, Litaker M, Thompson W, Hess D: The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992, 326: 605-610. 10.1056/NEJM199202273260905.CrossRefPubMed
15.
go back to reference Schwartz GJ, Furth SL: Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol. 2007, 22: 1839-1848. 10.1007/s00467-006-0358-1.CrossRefPubMed Schwartz GJ, Furth SL: Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol. 2007, 22: 1839-1848. 10.1007/s00467-006-0358-1.CrossRefPubMed
16.
go back to reference Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976, 58: 259-263.PubMed Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976, 58: 259-263.PubMed
17.
go back to reference Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL: New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009, 20: 629-637. 10.1681/ASN.2008030287.CrossRefPubMedPubMedCentral Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL: New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009, 20: 629-637. 10.1681/ASN.2008030287.CrossRefPubMedPubMedCentral
18.
go back to reference Staples A, Leblond R, Watkins S, Wong C, Brandt J: Validation of the revised Schwartz estimating equation in a predominantly non-CKD population. Pediatr Nephrol. 2010, 25: 2321-2326. 10.1007/s00467-010-1598-7.CrossRefPubMed Staples A, Leblond R, Watkins S, Wong C, Brandt J: Validation of the revised Schwartz estimating equation in a predominantly non-CKD population. Pediatr Nephrol. 2010, 25: 2321-2326. 10.1007/s00467-010-1598-7.CrossRefPubMed
19.
go back to reference National High Blood Pressure Education Program (US): Rev. ed. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. 2005, Bethesda (MD): National Heart, Lung, and Blood Institute (US), 48-NIH publication; no. 05–5267 National High Blood Pressure Education Program (US): Rev. ed. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. 2005, Bethesda (MD): National Heart, Lung, and Blood Institute (US), 48-NIH publication; no. 05–5267
20.
go back to reference Yee M, Jabbar SF, Osunkwo I, Clement L, Lane PA, Eckman JR, Guasch A: Chronic kidney disease and albuminuria in children with sickle cell disease. Clin J Am Soc Nephrol. 2011, 6: 2628-2633. 10.2215/CJN.01600211.CrossRef Yee M, Jabbar SF, Osunkwo I, Clement L, Lane PA, Eckman JR, Guasch A: Chronic kidney disease and albuminuria in children with sickle cell disease. Clin J Am Soc Nephrol. 2011, 6: 2628-2633. 10.2215/CJN.01600211.CrossRef
21.
go back to reference Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, UscinskiKnob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010, 329: 841-845. 10.1126/science.1193032.CrossRefPubMedPubMedCentral Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, UscinskiKnob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010, 329: 841-845. 10.1126/science.1193032.CrossRefPubMedPubMedCentral
22.
go back to reference Ashley-Koch AE, Okocha EC, Garrett ME, Soldano K, De Castro LM, Jonassaint JC, Orringer EP, Eckman JR, Telen MJ: MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol. 2011, 155: 386-394. 10.1111/j.1365-2141.2011.08832.x.CrossRefPubMed Ashley-Koch AE, Okocha EC, Garrett ME, Soldano K, De Castro LM, Jonassaint JC, Orringer EP, Eckman JR, Telen MJ: MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol. 2011, 155: 386-394. 10.1111/j.1365-2141.2011.08832.x.CrossRefPubMed
23.
go back to reference Aaronson IA, Mann MD: Measurement of glomerular filtration rate in children using technetium-99m diethylenetri- amine penta-acetic acid. S Afr Med J. 1985, 67: 507-509.PubMed Aaronson IA, Mann MD: Measurement of glomerular filtration rate in children using technetium-99m diethylenetri- amine penta-acetic acid. S Afr Med J. 1985, 67: 507-509.PubMed
24.
go back to reference Notghi A, Merrick MV, Ferrington C, Anderton JL: A comparison of simplified and standard methods for the measurement of glomerular filtration rate and renal tubular function. Br J Radiol. 1986, 59: 35-39. 10.1259/0007-1285-59-697-35.CrossRefPubMed Notghi A, Merrick MV, Ferrington C, Anderton JL: A comparison of simplified and standard methods for the measurement of glomerular filtration rate and renal tubular function. Br J Radiol. 1986, 59: 35-39. 10.1259/0007-1285-59-697-35.CrossRefPubMed
25.
go back to reference Russell CD, Bischoff CG, Rowell KL, Kontzen F, Lloyd LK, Tauxe WN, Dubovsky EV: Quality control of Tc-99m DTPA for measurement of glomerular filtration: concise communication. J Nucl Med. 1983, 24: 722-727.PubMed Russell CD, Bischoff CG, Rowell KL, Kontzen F, Lloyd LK, Tauxe WN, Dubovsky EV: Quality control of Tc-99m DTPA for measurement of glomerular filtration: concise communication. J Nucl Med. 1983, 24: 722-727.PubMed
26.
go back to reference Perrone RD, Steinman TI, Beck GJ, Skibinsky CI, Royal HD, Lawlor M, Hunsicker LG: Utility of radioisotopic filtration markers in chronic renal insufficiency: Simultaneous comparison of 125I-Iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1990, 16: 224-235.CrossRefPubMed Perrone RD, Steinman TI, Beck GJ, Skibinsky CI, Royal HD, Lawlor M, Hunsicker LG: Utility of radioisotopic filtration markers in chronic renal insufficiency: Simultaneous comparison of 125I-Iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1990, 16: 224-235.CrossRefPubMed
27.
go back to reference Rodman J, Maneval D, Magill L, Sunderland M: Measurement of Tc99m DTPA serum clearance for estimating glomerular filtration rate in children with cancer. Pharmacotherapy. 1993, 13: 10-16.PubMed Rodman J, Maneval D, Magill L, Sunderland M: Measurement of Tc99m DTPA serum clearance for estimating glomerular filtration rate in children with cancer. Pharmacotherapy. 1993, 13: 10-16.PubMed
28.
go back to reference Rehling M, Moller ML, Thamdrup B, Lund JO, Trap-Jensen J: Simultaneous measurement of renal clearance and plasma clearance of 99mTc- labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetraacetate and inulin in man. Clin Sci. 1984, 66: 613-619.CrossRefPubMed Rehling M, Moller ML, Thamdrup B, Lund JO, Trap-Jensen J: Simultaneous measurement of renal clearance and plasma clearance of 99mTc- labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetraacetate and inulin in man. Clin Sci. 1984, 66: 613-619.CrossRefPubMed
29.
go back to reference Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware RE: Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr Nephrol. 2011, 26: 1285-1290. 10.1007/s00467-011-1857-2.CrossRefPubMedPubMedCentral Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware RE: Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr Nephrol. 2011, 26: 1285-1290. 10.1007/s00467-011-1857-2.CrossRefPubMedPubMedCentral
30.
go back to reference Imuetinyan BA-I, Okoeguale MI, Egberue GO: Microalbuminuria in children with sickle cell anemia. SJKDT. 2011, 22: 733-738. Imuetinyan BA-I, Okoeguale MI, Egberue GO: Microalbuminuria in children with sickle cell anemia. SJKDT. 2011, 22: 733-738.
31.
go back to reference Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ: Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics. 2004, 113: 475-482. 10.1542/peds.113.3.475.CrossRefPubMed Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ: Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics. 2004, 113: 475-482. 10.1542/peds.113.3.475.CrossRefPubMed
32.
go back to reference Shatat IF, Jakson SM, Blue AE, Johnson MA, Orak JK, Kalpatthi R: Masked hypertension is prevalent in children with sickle cell disease: a Midwest pediatric nephrology consortium study. Pediatr Nephrol. 2012, 28: 115-120.CrossRefPubMed Shatat IF, Jakson SM, Blue AE, Johnson MA, Orak JK, Kalpatthi R: Masked hypertension is prevalent in children with sickle cell disease: a Midwest pediatric nephrology consortium study. Pediatr Nephrol. 2012, 28: 115-120.CrossRefPubMed
33.
go back to reference Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B, for the CKiD Study Group: Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010, 21: 137-144. 10.1681/ASN.2009060609.CrossRefPubMedPubMedCentral Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B, for the CKiD Study Group: Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010, 21: 137-144. 10.1681/ASN.2009060609.CrossRefPubMedPubMedCentral
34.
go back to reference Becton LJ, Kalpatthi RV, Rackoff E, Disco D, Orak JK, Jackson SM, Shatat IF: Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol. 2010, 25: 1505-1511. 10.1007/s00467-010-1536-8.CrossRefPubMed Becton LJ, Kalpatthi RV, Rackoff E, Disco D, Orak JK, Jackson SM, Shatat IF: Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol. 2010, 25: 1505-1511. 10.1007/s00467-010-1536-8.CrossRefPubMed
35.
go back to reference de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM: Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Arch Intern Med. 2011, 171: 412-420. 10.1001/archinternmed.2011.16.CrossRefPubMedPubMedCentral de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM: Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Arch Intern Med. 2011, 171: 412-420. 10.1001/archinternmed.2011.16.CrossRefPubMedPubMedCentral
36.
go back to reference Schwartz GJ, Lerner NB: The kallikrein-kinin system in sickle cell nephropathy: does it play a role?. J Pediatr Hematol Oncol. 2006, 28: 111-114. 10.1097/01.mph.0000203718.37824.2e.CrossRefPubMed Schwartz GJ, Lerner NB: The kallikrein-kinin system in sickle cell nephropathy: does it play a role?. J Pediatr Hematol Oncol. 2006, 28: 111-114. 10.1097/01.mph.0000203718.37824.2e.CrossRefPubMed
37.
go back to reference Bergmann S, Zheng D, Barredo J, Abboud M, Jaffa A: Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease. J Pediatr Hematol Oncol. 2006, 28: 147-153. 10.1097/01.mph.0000203722.91189.9d.CrossRefPubMed Bergmann S, Zheng D, Barredo J, Abboud M, Jaffa A: Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease. J Pediatr Hematol Oncol. 2006, 28: 147-153. 10.1097/01.mph.0000203722.91189.9d.CrossRefPubMed
38.
go back to reference Mohtat D, Thomas R, Du Z, Boakye Y, Moulton T, Driscoll C, Woroniecki R: Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease. Pediatr Nephrol. 2011, 26: 275-280. 10.1007/s00467-010-1677-9.CrossRefPubMed Mohtat D, Thomas R, Du Z, Boakye Y, Moulton T, Driscoll C, Woroniecki R: Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease. Pediatr Nephrol. 2011, 26: 275-280. 10.1007/s00467-010-1677-9.CrossRefPubMed
39.
go back to reference Tharaux P, Hagege I, Placier S, Vayssairat M, Kanfer A, Girot R, Dussaule J: Urinary endothelin-1 as a marker of renal damage in sickle cell disease. Nephrol Dial Transplant. 2005, 20: 2408-2413. 10.1093/ndt/gfi111.CrossRefPubMed Tharaux P, Hagege I, Placier S, Vayssairat M, Kanfer A, Girot R, Dussaule J: Urinary endothelin-1 as a marker of renal damage in sickle cell disease. Nephrol Dial Transplant. 2005, 20: 2408-2413. 10.1093/ndt/gfi111.CrossRefPubMed
40.
go back to reference Sundaram N, Bennett M, Wilhelm J, Kim M-O, Atweh G, Devarajan P, Malik P: Biomarkers for early detection of sickle nephropathy. Am J Hematol. 2011, 86: 559-566. 10.1002/ajh.22045.CrossRefPubMedPubMedCentral Sundaram N, Bennett M, Wilhelm J, Kim M-O, Atweh G, Devarajan P, Malik P: Biomarkers for early detection of sickle nephropathy. Am J Hematol. 2011, 86: 559-566. 10.1002/ajh.22045.CrossRefPubMedPubMedCentral
41.
go back to reference Lu L, Sedor JR, Gulani V, Schelling JR, O’Brien A, Flask CA, MacRae Dell K: Use of diffusion tensor MRI to identify early changes in diabetic nephropathy. Am J Nephrol. 2011, 34: 476-482. 10.1159/000333044.CrossRefPubMedPubMedCentral Lu L, Sedor JR, Gulani V, Schelling JR, O’Brien A, Flask CA, MacRae Dell K: Use of diffusion tensor MRI to identify early changes in diabetic nephropathy. Am J Nephrol. 2011, 34: 476-482. 10.1159/000333044.CrossRefPubMedPubMedCentral
Metadata
Title
The prevalence of hypertension and abnormal kidney function in children with sickle cell disease –a cross sectional review
Authors
Prasad Bodas
Alex Huang
Mary Ann O’Riordan
John R Sedor
Katherine MacRae Dell
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-237

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.